RhumbLine Advisers’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Buy |
204,665
+15,065
| +8% | +$135K | ﹤0.01% | 1956 |
|
|
2026
Q1 | $1.54M | Sell |
189,600
-155
| -0.1% | -$1.41K | ﹤0.01% | 1993 |
|
|
2025
Q4 | $1.28M | Sell |
189,755
-32,320
| -15% | -$244K | ﹤0.01% | 2103 |
|
|
2025
Q3 | $1.93M | Sell |
222,075
-9,842
| -4% | -$76.6K | ﹤0.01% | 1931 |
|
|
2025
Q2 | $1.46M | Buy |
231,917
+16,504
| +8% | +$109K | ﹤0.01% | 2057 |
|
|
2025
Q1 | $1.38M | Buy |
215,413
+6,949
| +3% | +$57.4K | ﹤0.01% | 2017 |
|
|
2024
Q4 | $1.68M | Buy |
208,464
+13,024
| +7% | +$126K | ﹤0.01% | 1982 |
|
|
2024
Q3 | $2.47M | Sell |
195,440
-4,469
| -2% | -$57.7K | ﹤0.01% | 1797 |
|
|
2024
Q2 | $2.53M | Buy |
199,909
+56,324
| +39% | +$567K | ﹤0.01% | 1764 |
|
|
2024
Q1 | $686K | Buy |
143,585
+12,905
| +10% | +$59.9K | ﹤0.01% | 2469 |
|
|
2023
Q4 | $627K | Buy |
130,680
+6,538
| +5% | +$40K | ﹤0.01% | 2531 |
|
|
2023
Q3 | $899K | Buy |
124,142
+834
| +0.7% | +$6.66K | ﹤0.01% | 2266 |
|
|
2023
Q2 | $916K | Buy |
123,308
+25,235
| +26% | +$198K | ﹤0.01% | 2337 |
|
|
2023
Q1 | $680K | Buy |
98,073
+16,055
| +20% | +$148K | ﹤0.01% | 2300 |
|
|
2022
Q4 | $843K | Sell |
82,018
-11
| -0% | -$194 | ﹤0.01% | 2227 |
|
|
2022
Q3 | $1.49M | Buy |
82,029
+2,099
| +3% | +$91K | ﹤0.01% | 1934 |
|
|
2022
Q2 | $4.11M | Buy |
79,930
+7,678
| +11% | +$398K | 0.01% | 1349 |
|
|
2022
Q1 | $5.32M | Sell |
72,252
-6,270
| -8% | -$559K | 0.01% | 1271 |
|
|
2021
Q4 | $11.2M | Buy |
78,522
+4,251
| +6% | +$730K | 0.01% | 925 |
|
|
2021
Q3 | $15.4M | Sell |
74,271
-973
| -1% | -$214K | 0.02% | 729 |
|
|
2021
Q2 | $16M | Sell |
75,244
-21,870
| -23% | -$4.01M | 0.02% | 733 |
|
|
2021
Q1 | $17.6M | Sell |
97,114
-4,384
| -4% | -$874K | 0.02% | 653 |
|
|
2020
Q4 | $11.3M | Buy |
101,498
+8,428
| +9% | +$896K | 0.02% | 840 |
|
|
2020
Q3 | $10.1M | Sell |
93,070
-14,639
| -14% | -$1.78M | 0.02% | 770 |
|
|
2020
Q2 | $8.98M | Buy |
107,709
+58,613
| +119% | +$2.24M | 0.02% | 834 |
|
|
2020
Q1 | $667K | Buy |
49,096
+15,998
| +48% | +$135K | ﹤0.01% | 2045 |
|
|
2019
Q4 | $132K | Sell |
33,098
-330
| -1% | -$1.43K | ﹤0.01% | 2843 |
|
|
2019
Q3 | $168K | Buy |
33,428
+3,118
| +10% | +$17.1K | ﹤0.01% | 2789 |
|
|
2019
Q2 | $178K | Buy |
30,310
+4,107
| +16% | +$32.3K | ﹤0.01% | 2822 |
|
|
2019
Q1 | $289K | Sell |
26,203
-508
| -2% | -$16K | ﹤0.01% | 2568 |
|
|
2018
Q4 | $983K | Buy |
26,711
+8,138
| +44% | +$315K | ﹤0.01% | 2024 |
|
|
2018
Q3 | $698K | Sell |
18,573
-219
| -1% | -$6.17K | ﹤0.01% | 2149 |
|
|
2018
Q2 | $504K | Buy |
18,792
+3,484
| +23% | +$118K | ﹤0.01% | 2311 |
|
|
2018
Q1 | $643K | Buy |
15,308
+468
| +3% | +$18.8K | ﹤0.01% | 2118 |
|
|
2017
Q4 | $368K | Sell |
14,840
-2,665
| -15% | -$65K | ﹤0.01% | 2361 |
|
|
2017
Q3 | $399K | Buy |
17,505
+157
| +0.9% | +$3.52K | ﹤0.01% | 2425 |
|
|
2017
Q2 | $399K | Buy |
17,348
+1,170
| +7% | +$23K | ﹤0.01% | 2415 |
|
|
2017
Q1 | $414K | Buy |
16,178
+562
| +4% | +$15.5K | ﹤0.01% | 2335 |
|
|
2016
Q4 | $394K | Buy |
15,616
+1,031
| +7% | +$30.1K | ﹤0.01% | 2347 |
|
|
2016
Q3 | $607K | Buy |
14,585
+99
| +0.7% | +$12.8K | ﹤0.01% | 2090 |
|
|
2016
Q2 | $2.11M | Buy |
14,486
+743
| +5% | +$85.2K | 0.01% | 1304 |
|
|
2016
Q1 | $1.42M | Buy |
13,743
+149
| +1% | +$16K | ﹤0.01% | 1594 |
|
|
2015
Q4 | $2.28M | Buy |
13,594
+1,520
| +13% | +$234K | 0.01% | 1275 |
|
|
2015
Q3 | $1.71M | Buy |
12,074
+428
| +4% | +$96K | 0.01% | 1415 |
|
|
2015
Q2 | $2.6M | Buy |
11,646
+497
| +4% | +$87.4K | 0.01% | 1235 |
|
|
2015
Q1 | $1.84M | Buy |
11,149
+2,084
| +23% | +$338K | 0.01% | 1452 |
|
|
2014
Q4 | $1.07M | Buy |
9,065
+298
| +3% | +$31.1K | ﹤0.01% | 1756 |
|
|
2014
Q3 | $731K | Buy |
8,767
+172
| +2% | +$15.5K | ﹤0.01% | 1979 |
|
|
2014
Q2 | $794K | Buy |
8,595
+1,463
| +21% | +$129K | ﹤0.01% | 1984 |
|
|
2014
Q1 | $646K | Buy |
7,132
+119
| +2% | +$13.3K | ﹤0.01% | 2051 |
|
|
2013
Q4 | $718K | Buy |
7,013
+953
| +16% | +$67.3K | ﹤0.01% | 2028 |
|
|
2013
Q3 | $383K | Sell |
6,060
-60
| -1% | -$3.38K | ﹤0.01% | 2377 |
|
|
2013
Q2 | $251K | Buy |
+6,120
| New | +$265K | ﹤0.01% | 2799 |
|
Other funds holding NVAX
SCM
S
RhumbLine Advisers's NVAX Position: Q2 2026 in Review
RhumbLine Advisers increased its Novavax (NVAX) stake by 7.9% in Q2 2026, buying an estimated $135K and bringing the position to 204,665 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1956.
RhumbLine Advisers first reported a position in NVAX in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.6M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- RhumbLine Advisers held 204,665 shares of Novavax worth $1.93M as of Q2 2026.
- RhumbLine Advisers bought 15,065 Novavax shares in Q2 2026, an estimated $135K.
- Novavax made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1956 holding.
- RhumbLine Advisers first reported a position in Novavax in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Novavax position peaked at $17.6M in Q1 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.